Pharmaceutical companies & contract research organizations (CRO)

WinterLight’s assessment provides a quick and objective way to identify and assess patients and improve assessment quality assurance (QA).

How can WinterLight's platform help your organization?

Patient identification & screening

Use WinterLight's assessment to help screen and identify participants for clinical trials. WinterLight uses AI to interpret hundreds of speech and language variables to accurately infer cognitive status.

Quality assurance (QA)

Standard cognitive assessments include components which are subjectively scored. WinterLight can objectively and automatically analyze and score verbal responses from current assessments.

Response to therapy

Use WinterLight's assessment to quickly track and analyze hundreds of speech and language variables that might be impacted by treatment (e.g. prosody, sentence complexity, word-finding difficulties, etc).

WinterLight’s assessment takes 2 minutes to administer by a caregiver, personal support worker, or a family member. Neurologically healthy people can even self-administer the assessment remotely.

Improved methods for accurate diagnosis and monitoring will be critical to ensure timely and appropriate treatment of cognitive and mental health diseases. WinterLight’s technology offers improved, quality assurance, objectivity and time savings for pharmaceutical companies and contract research organizations (CROs) working in areas related to Alzheimer's disease, aphasia, multiple sclerosis, traumatic brain injury, and other disorders of the central nervous system.

Using recorded samples of a person’s speech, WinterLight’s platform analyzes hundreds of linguistic cues and can detect dementia and other conditions accuracies between 82% and 100%. Learn more about our peer-reviewed research and our team of experts. If your organization is interested in leveraging our technology to identify patients or monitor response to therapy in a clinical trial or in clinical settings, please contact us (